# Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

> clinical trial · VERIFIED · 2026-09-01

Status: RECRUITING · Sponsor: Pharvaris Netherlands B.V. · Condition: Hereditary Angioedema (HAE)

- Company: Pharvaris Netherlands B.V.
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT06679881

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.